Home Welcome The Faculty Graduate Program Post-Doctoral Programs Calendar of Events Department/Campus Life Contact Us


Faculty Biography



Address:
Physicians & Surgeons
Room 7-422
630 West 168th St.
New York, NY   10032

Phone: 212-305-0321
Fax: 212-305-0991

hc2405@columbia.edu

Education and Training
Ph.D.

Affiliations
- Physiology & Cellular Biophysics
- Pharmacology


Training Activities
-Graduate Program in Pharmacology









Henry Colecraft, Ph.D.
Associate Professor of Physiology and Cellular Biophysics


Research Summary
MOLECULAR PHYSIOLOGY OF VOLTAGE-DEPENDENT CALCIUM CHANNELS.

Structure-function mechanisms of CaV channel b subunits.
Voltage-dependent calcium (CaV) channels are multi-subunit protein complexes comprised of a main pore-forming a1 subunit and associated accessory proteins. Of the accessory proteins, b subunits (CaVb) are arguably the most important, being necessary for targeting the channel to the membrane and normalizing channel gating (the manner in which the channel opens and closes). Their essential role is emphasized by the severe neurological and cardiovascular phenotypes ensuing from CaVb dysregulation: epilepsy, altered threshold to pain, night blindness, and defects in cardiac development. We aim to understand: (1) at a quantitative level the mechanisms by which CaVbs exert such powerful effects on CaV channels; (2) the role of the a1-b interaction in disease; and (3) the potential of the a1-b association as a target for therapeutic drugs. A powerful complement of approaches is used including: whole-cell and single-channel patch clamp electrophysiology, fluorescence resonance energy transfer (FRET) determination of protein-protein interactions, molecular biology, bioinformatics, and modeling.

Design of novel genetically-encoded CaV channel inhibitors.
Blockade of CaV channels is a therapeutic strategy for an impressive array of cardiovascular and neurological diseases including: angina, hypertension, stroke, migraines, neuropathic pain, and epilepsy. In the quest for more effective and selective CaV channel blockers, the CaV channel a1-b subunit interaction is recognized as a promising locus, although attempts to target this site in the past have met with only limited success. It was recently discovered that the Rem/Rad/Gem/Kir (RGK) sub-family of Ras-like GTPases potently inhibit CaV channels by interaction with CaVb subunits. How do these ‘natural genetically-encoded CaV channel blockers’ work? Can we learn from Nature’s design to create a new generation of custom CaV channel blockers? We are taking cues from this remarkable protein family to create useful new genetically encoded CaV channel blockers for various customized applications.

Reverse engineering CaV channels in heart and neurons.
CaV channels are central to biological function in heart and nerve cells, being necessary for generating the heartbeat, nerve cell communications, and regulation of gene expression. In the complicated cellular environment of heart cells and neurons, the mechanistic bases of CaV channel functions are often obscure, akin to a biological ‘black box’. To elucidate mysterious aspects of CaV channel behavior in such native cells we employ a reverse engineering approach where viral-mediated gene delivery permits selective genetic manipulation of CaV channel properties in heart and neuronal cells. Questions we are interested in addressing include: How are different CaV channels targeted to spatially distinct sites in heart and neurons? What mechanisms underlie CaV channel regulation by messenger molecules in heart and neurons? To address these, we combine viral-mediated gene delivery, quantitative confocal imaging, and electrophysiological approaches.
http://www.physiology.columbia.edu/colecraft.html


Selected Publications:
1. Yang T, Suhail Y, Dalton S, Kernan T, Colecraft HM. (2007) Genetically Encoded Molecules for Inducibly Inactivating CaV Channels. Nature Chem. Bio., In Press :

2. Takahashi SX, Miriyala J, Tay LH, Yue DT, Colecraft HM. (2005) A CaVb SH3-GK interaction regulates multiple properties of voltage-gated Ca2+ channels. J. Gen. Physiol. 126:365-377

3. Dalton S, Takahashi SX, Miriyala J, Colecraft HM. (2005) A single CaVb can reconstitute both trafficking and macroscopic conductance of voltage-dependent calcium channels. J. Physiol. 567:757-769

4. Agler HL, Evans J, Tay L-H, Anderson MJ, Colecraft HM, Yue DT. (2005) G-protein gated inhibitory module of N-type (CaV2.2) Ca2+ channels. Neuron 46:891-904

5. Takahashi SX, Miriyala J, Colecraft HM. (2004) Membrane-associated guanylate kinase-like properties of b-subunits required for modulation of voltage-dependent Ca2+ channels. Proc. Natl. Acad. Sci. 101:7193-7198

6. Takahashi SX, Mittman S, Colecraft HM. (2003) Distinctive modulatory properties of five human auxiliary b2 subunit splice variants on L-type Ca2+ channel gating. Biophys. J. 84:3007-3021

7. Alseikhan BA, DeMaria CD, Colecraft HM, Yue DT. (2002) Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation. Proc. Natl. Acad. Sci. 99:17185-17190

8. Colecraft HM, Alseikhan BA, Takahashi SX, Chaudhury D, Mittman S, Yegnasubramanian V, Alvania RS, Johns DC, Marban E, Yue DT. (2002) Novel functional properties of Ca2+ channel b subunits revealed by their expression in adult heart cells. J. Physiol. 541:435-452



top


CUMC Home | At Columbia University | Affiliated with New York-Presbyterian Hospital | Comments